+ All Categories
Home > Health & Medicine > Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Date post: 03-Jun-2015
Category:
Upload: patrick-treacy
View: 1,997 times
Download: 1 times
Share this document with a friend
Description:
Lecture about the benefits of the dermal implant Radiesse given at IMCAS Paris 2008 by Dr. Patrick Treacy. Learm more at http://www.ailesburyclinic.ie/
Popular Tags:
24
Clinical Research Data vs. vs.
Transcript
Page 1: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Clinical Research Data

vs. vs.

Page 2: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Medical Disclosure

• Dr. Patrick J. Treacy is a Cosmetic Dermatologist presently on the Specialist Register in Ireland

• I have purchased my own Radiesse product in Ailesbury Clinic.• I have no financial interest or stock in BioForm nor do I receive

any additional remuneration or other compensation for product bought by you as a result of your attendance at this IMAS lecture.

Page 3: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Multi-Centre Research Data

vs. vs.

•Multi Centre •Randomised•Blinded •Comparative Study

Results published in the Dec 2007 Journal of Dermatological Surgery

Page 4: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Comparative StudyRadiesse vs Perlane vs Juvederm 24/24HV

(N=205)

• Comparison of efficacy, durability, and patient satisfaction variables

• Treatment of Nasolabial Folds– Month 0 and 4.

• Results at 4, 8, and 12 month post 2nd injection

Page 5: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Head to Head Studies

1. Radiesse vs. Restylane Trial Design (2 sites)– Split face study, n=60– GAIS, WSRS, and Injection Volume– Live Blinded Evaluator and patient satisfaction questionnaires

2. Radiesse vs. Juvederm & Perlane Trial Design (5 sites)– Patients randomized to one of three treatments (both NL-folds), n=205– GAIS, WSRS, and Injection Volume– Live Blinded Evaluator and patient satisfaction questionnaires

6 Months 9 Months3 Months0 Months

12 Months8 Months4 Months0 Months

Page 6: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Results after 1st treatment

Less volume

Page 7: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

vsRestylane

Page 8: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

vs Restylane

Page 9: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

% of Patients Improved or better (n=60 Split Face)% of Patients Improved or better (n=60 Split Face)% of Patients Improved or better (n=60 Split Face)% of Patients Improved or better (n=60 Split Face)

3 Months 6 Months 9 Months0%

20%

40%

60%

80%

100%

RadiesseRestylane

79%

44%

More Patients improved with Radiesse than with Restylane

Time post 2nd Injection

Comparative Study: Radiesse vs RestylaneGAIS

Page 10: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

WSRS = Wrinkle Severity Rating Scale

5 Extreme Extremely deep and long folds, detrimental to facial appearance.

2-4mm Visible V-shaped fold when stretched

Unlikely to have satisfactory correction with injectable implant alone.

4 Severe Very long and deep folds; prominent facial feature.

Less than 2mm visible fold when stretched.

Significant improvement is expected from injectable implant.

3 Moderate Moderately deep folds.

Clear facial feature visible at normal appearance but not when stretched.

Excellent correction is expected from injectable implant.

2 Mild Shallow but visible fold with a slight indentation; minor facial feature.

Implant is expected to produce a slight improvement in appearance.

1 Absent No visible fold, continuous skin line.

1 5

4

3

2

Page 11: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

GAIS = Global Aesthetic Improvement Scale

Very Much Improved Optimal cosmetic result for the implant in this patient.

Much Improved Marked improvement in appearance but not completely optimal for this patient. A touch-up would slightly improve the result.

Improved Obvious improvement in appearance from the initial condition, but a touch-up or re-treatment is indicated.

No Change The appearance is essentially the same as the original condition.

Worse The appearance is worse than the original condition.

Page 12: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Comparative StudyRadiesse vs Perlane vs Juvederm 24/24HV

(N=205)

• Comparison of efficacy, durability, and patient satisfaction variables

• Treatment of Nasolabial Folds– Month 0 and 4.

• Results at 4, 8, and 12 month post 2nd injection

Page 13: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

% of Patients Improved or better (n=205)% of Patients Improved or better (n=205)% of Patients Improved or better (n=205)% of Patients Improved or better (n=205)

4 Months 8 Months 12 Months

0%

20%

40%

60%

80%

100%RadiessePerlaneJuvederm HV

More Patients improved with Radiesse than with Perlane & Juvederm

Time post 2nd Injection

62%

50%48%

88%

53%

64%

Comparative StudyRadiesse vs Perlane vs Juvederm 24/24HV

GAIS

Page 14: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

One fold (split face)(touch up at 3 Months)

Both folds(touch up at 4 Months)

Radiesse 0.89

Restylane 1.26

Radiesse 2.21

Perlane

2.89

Juvederm HV

2.940 1 2 3Volume Required to Achieve Optimal Correction (cc)

cc - including touch up

Syringes needed for 2 Folds

Full Correction

1.4

2.5

1.7

2.9

3.7

% of OptimalCorrection w/One Syringe

70%

40%

60%

34%

27%

Volume Comparison

Page 15: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

% of Patients That are Satisfied & Extremely Satisfied*% of Patients That are Satisfied & Extremely Satisfied*% of Patients That are Satisfied & Extremely Satisfied*% of Patients That are Satisfied & Extremely Satisfied*

89%

61% 58%

96%

6 Months 9 Months

More patients were Satisfied with Radiesse than with Restylane, even at 6 Months

Time post 2nd Injection

Radiesse

Restylane

Comparative Study: Radiesse vs RestylanePatient Satisfaction

Page 16: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

% of Patients That are Satisfied & Extremely Satisfied% of Patients That are Satisfied & Extremely Satisfied% of Patients That are Satisfied & Extremely Satisfied% of Patients That are Satisfied & Extremely Satisfied

97%90%

95%

48%

58%

73%

4 Months 8 Months 12 Months

RadiessePerlaneJuvederm Juvederm HV

More patients were Satisfied with Radiesse than with Perlane or Juvederm

Time post 2nd Injection

Comparative StudyRadiesse vs Perlane vs Juvederm 24/24HV

Patient Satisfaction

Page 17: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

% of Patients who say that they are Likely or % of Patients who say that they are Likely or Extremely Likely to return for future treatments Extremely Likely to return for future treatments

% of Patients who say that they are Likely or % of Patients who say that they are Likely or Extremely Likely to return for future treatments Extremely Likely to return for future treatments

Patients are 3 times more likely to return for re-treatments with Radiesse

24% 25%

75% 75%

6 Months 9 MonthsTime post 2nd Injection

RadiesseRestylane

Comparative Study: Radiesse vs RestylanePatients likely to return

Page 18: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

98%

35%

43%38%

93%92%

4 Months 8 Months 12 Months

RadiessePerlaneJuvederm Juvederm HV

Patients are much more likely to come in for re-treatments with Radiesse

Time post 2nd Injection

% of Patients who say that they are Likely or % of Patients who say that they are Likely or Extremely Likely to return for future treatments Extremely Likely to return for future treatments

% of Patients who say that they are Likely or % of Patients who say that they are Likely or Extremely Likely to return for future treatments Extremely Likely to return for future treatments

Comparative StudyRadiesse vs Perlane vs Juvederm 24/24HV

Patients likely to return

Page 19: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

• Radiesse treated patients are more satisfied compared to hyaluronic acid treated patients

• Radiesse delivers better correction at 3 months & beyond

• Radiesse delivers longer-lasting correction

• Radiesse requires less volume to achieve the same immediate correction

• Radiesse patients are more likely to return for future treatments

Comparative Studies with RadiesseSUMMAY FINDINGS

Page 20: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Acknowledgements and Participating Centers

Marion Moers-Carpi, Munich, Germany

Stephan Vogt, Hanover, Germany

Jaime Opi Tufet, Barcelona, Spain

Begonia Martinez Santos, Barcelona, Spain

Jorge Planas, Barcelona, Spain

Sonia Rovira Vallve, Barcelona, Spain

Page 21: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Calcium Hydroxylapatite

Gel carrier (~70%)

Sodium-CarboxyMethylCelluloseGlycerineH2O

Structural component (~30%)Ca2+ PO4

3- ions (Ca10(PO4)6(OH)2)

Natural mineral (identical to teeth & bone)

Page 22: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Calcium Hydroxylapatite

Macrophages dissolve gel carrier & fibroblasts form new collagen.

Natural mineral non-antigenic, non-irritant, non-toxic metabolizes via homeostatic mechanisms

Page 23: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Facial Augmentation

Nasolabial Fold

Mental creaseJaw Line

Chin

Post-rhinoplasty

Marionette Line

Cheek

Malar

Radial Lip Lines

Page 24: Dr. Patrick Treacy lecture on Radiesse to IMCAS 2008

Recommended